The majority of treatments for neurological diseases involve drugs. Yet maintaining a steady state of medications in a person’s system may not be effective in targeting abnormal brain activity that is transient and oscillating. Therefore, patients may have to continually take drugs for conditions that only manifest themselves intermittently – such as with seizures – or to take drugs that disrupt normal brain activity. With a view to developing non-pharmacological interventions, this team is dedicated to measuring – and ultimately managing – disrupted brain function occurring at short temporal scales. Focusing initially on Parkinson’s Disease, the team is working to better pinpoint and understand subtle oscillations in abnormal brain activity, and developing and testing visual stimuli systems that have shown promise in disrupting these abnormal oscillations in the brain. The findings from this research will have broader impact with implications for many brain diseases.